380 related articles for article (PubMed ID: 17265488)
21. Suppression of immune responses in collagen-induced arthritis by a rationally designed CD80-binding peptide agent.
Srinivasan M; Eri R; Zunt SL; Summerlin DJ; Brand DD; Blum JS
Arthritis Rheum; 2007 Feb; 56(2):498-508. PubMed ID: 17265485
[TBL] [Abstract][Full Text] [Related]
22. Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease.
Delgado M; Abad C; Martinez C; Leceta J; Gomariz RP
Nat Med; 2001 May; 7(5):563-8. PubMed ID: 11329057
[TBL] [Abstract][Full Text] [Related]
23. The therapeutic effect of vasoactive intestinal peptide on experimental arthritis is associated with CD4+CD25+ T regulatory cells.
Chen G; Hao J; Xi Y; Wang W; Wang Z; Li N; Li W
Scand J Immunol; 2008 Dec; 68(6):572-8. PubMed ID: 19055696
[TBL] [Abstract][Full Text] [Related]
24. Effects of a novel tylophorine analog on collagen-induced arthritis through inhibition of the innate immune response.
You X; Pan M; Gao W; Shiah HS; Tao J; Zhang D; Koumpouras F; Wang S; Zhao H; Madri JA; Baker D; Cheng YC; Yin Z
Arthritis Rheum; 2006 Mar; 54(3):877-86. PubMed ID: 16508970
[TBL] [Abstract][Full Text] [Related]
25. Treatment of collagen-induced arthritis by Natura-alpha via regulation of Th-1/Th-17 responses.
Glatigny S; Blaton MA; Mencher SK; Mistou S; Lucas B; Fournier C; Wang LG; Chiocchia G
Eur J Immunol; 2010 Feb; 40(2):460-9. PubMed ID: 20077403
[TBL] [Abstract][Full Text] [Related]
26. A comparative study into the mechanisms of action of anti-tumor necrosis factor alpha, anti-CD4, and combined anti-tumor necrosis factor alpha/anti-CD4 treatment in early collagen-induced arthritis.
Marinova-Mutafchieva L; Williams RO; Mauri C; Mason LJ; Walmsley MJ; Taylor PC; Feldmann M; Maini RN
Arthritis Rheum; 2000 Mar; 43(3):638-44. PubMed ID: 10728758
[TBL] [Abstract][Full Text] [Related]
27. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis.
Andreakos E; Rauchhaus U; Stavropoulos A; Endert G; Wendisch V; Benahmed AS; Giaglis S; Karras J; Lee S; Gaus H; Bennett CF; Williams RO; Sideras P; Panzner S
Arthritis Rheum; 2009 Apr; 60(4):994-1005. PubMed ID: 19333921
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic action of ghrelin in a mouse model of colitis.
Gonzalez-Rey E; Chorny A; Delgado M
Gastroenterology; 2006 May; 130(6):1707-20. PubMed ID: 16697735
[TBL] [Abstract][Full Text] [Related]
29. Achievement of a synergistic adjuvant effect on arthritis induction by activation of innate immunity and forcing the immune response toward the Th1 phenotype.
Hanyecz A; Berlo SE; Szántó S; Broeren CP; Mikecz K; Glant TT
Arthritis Rheum; 2004 May; 50(5):1665-76. PubMed ID: 15146438
[TBL] [Abstract][Full Text] [Related]
30. Regulatory effect of daphnetin, a coumarin extracted from Daphne odora, on the balance of Treg and Th17 in collagen-induced arthritis.
Yao R; Fu Y; Li S; Tu L; Zeng X; Kuang N
Eur J Pharmacol; 2011 Nov; 670(1):286-94. PubMed ID: 21914445
[TBL] [Abstract][Full Text] [Related]
31. Collagen-induced arthritis in CD4- or CD8-deficient mice: CD8+ T cells play a role in initiation and regulate recovery phase of collagen-induced arthritis.
Tada Y; Ho A; Koh DR; Mak TW
J Immunol; 1996 Jun; 156(11):4520-6. PubMed ID: 8666829
[TBL] [Abstract][Full Text] [Related]
32. Immune modulation of collagen-induced arthritis by intranasal cytokine gene delivery: a model for the therapy of rheumatoid arthritis.
Woods AM; Thompson SJ; Wooley PH; Panayi G; Klavinskis LS
Arthritis Rheum; 2005 Dec; 52(12):3761-71. PubMed ID: 16329091
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells.
Cao Q; Wang L; Du F; Sheng H; Zhang Y; Wu J; Shen B; Shen T; Zhang J; Li D; Li N
Cell Res; 2007 Jul; 17(7):627-37. PubMed ID: 17563757
[TBL] [Abstract][Full Text] [Related]
34. Proinflammatory mediator-induced reversal of CD4+,CD25+ regulatory T cell-mediated suppression in rheumatoid arthritis.
van Amelsfort JM; van Roon JA; Noordegraaf M; Jacobs KM; Bijlsma JW; Lafeber FP; Taams LS
Arthritis Rheum; 2007 Mar; 56(3):732-42. PubMed ID: 17328044
[TBL] [Abstract][Full Text] [Related]
35. Regulatory effect of vasoactive intestinal peptide on the balance of Treg and Th17 in collagen-induced arthritis.
Deng S; Xi Y; Wang H; Hao J; Niu X; Li W; Tao Y; Chen G
Cell Immunol; 2010; 265(2):105-10. PubMed ID: 20716449
[TBL] [Abstract][Full Text] [Related]
36. Suppression of the onset and progression of collagen-induced arthritis by chebulagic acid screened from a natural product library.
Lee SI; Hyun PM; Kim SH; Kim KS; Lee SK; Kim BS; Maeng PJ; Lim JS
Arthritis Rheum; 2005 Jan; 52(1):345-53. PubMed ID: 15641090
[TBL] [Abstract][Full Text] [Related]
37. The beta2-adrenergic agonist salbutamol is a potent suppressor of established collagen-induced arthritis: mechanisms of action.
Malfait AM; Malik AS; Marinova-Mutafchieva L; Butler DM; Maini RN; Feldmann M
J Immunol; 1999 May; 162(10):6278-83. PubMed ID: 10229875
[TBL] [Abstract][Full Text] [Related]
38. Schistosoma mansoni infection reduces severity of collagen-induced arthritis via down-regulation of pro-inflammatory mediators.
Osada Y; Shimizu S; Kumagai T; Yamada S; Kanazawa T
Int J Parasitol; 2009 Mar; 39(4):457-64. PubMed ID: 18835272
[TBL] [Abstract][Full Text] [Related]
39. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.
Young DA; Hegen M; Ma HL; Whitters MJ; Albert LM; Lowe L; Senices M; Wu PW; Sibley B; Leathurby Y; Brown TP; Nickerson-Nutter C; Keith JC; Collins M
Arthritis Rheum; 2007 Apr; 56(4):1152-63. PubMed ID: 17393408
[TBL] [Abstract][Full Text] [Related]
40. Anti-IgD antibody attenuates collagen-induced arthritis by selectively depleting mature B-cells and promoting immune tolerance.
Nguyen TG; Little CB; Yenson VM; Jackson CJ; McCracken SA; Warning J; Stevens V; Gallery EG; Morris JM
J Autoimmun; 2010 Aug; 35(1):86-97. PubMed ID: 20456921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
